SYNAGEVA BIOPHARMA CORP 4
4 · SYNAGEVA BIOPHARMA CORP · Filed Jun 23, 2015
Insider Transaction Report
Form 4
Biggar Stephen R
Director
Transactions
- Disposition to Issuer
Common Stock
2015-06-22−102→ 0 total
Footnotes (1)
- [F1]Disposition of securities directly held by Stephen R. Biggar, an employee of Baker Bros. Advisors LP in connection with completion of the acquisition of Synageva Biopharma Corp. (the "Issuer") by Alexion Pharmaceuticals, Inc. pursuant to the Agreement and Plan of Reorganization (the "Merger Agreement") dated May 5, 2015, by and among Alexion Pharmaceuticals, Inc., the Issuer, Merger Sub Inc. and Galaxy Merger Sub LLC. Pursuant to the Merger Agreement the Issuer's common shares were exchanged for $115 in cash and 0.6581 share of Alexion Pharmaceuticals, Inc. common stock.